Literature DB >> 10458646

Evidence for calcitonin gene-related peptide-mediated ischemic preconditioning in the rat heart.

R Lu1, Y J Li, H W Deng.   

Abstract

Previous studies have suggested that calcitonin gene-related peptide (CGRP) may play an important role in the mediation of ischemic preconditioning. In the present study, we examined the release of CGRP during ischemic preconditioning and the effect of preconditioning frequency on this effect in the isolated rat heart. Thirty minutes of global ischemia and 40 min of reperfusion caused a significant cardiac dysfunction and an increase in the release of creatine kinase (CK) during reperfusion. Preconditioning with one, two or three cycles of 5-min ischemia and 5-min reperfusion caused a marked improvement of cardiac function and a decrease in the release of CK, and there was no difference in the degree of improvement among groups. The protective effects of ischemic preconditioning were abolished by the CGRP receptor antagonist CGRP(8-37). A single preconditioning cycle induced a significant increase in the release of CGRP in the coronary effluent. In the hearts treated with two or three preconditioning cycles, the level of CGRP was highest in the first cycle, and was gradually decreased with increasing number of cycles of preconditioning. These results suggest that the protective effects of ischemic preconditioning are mediated by endogenous CGRP in the isolated rat heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458646     DOI: 10.1016/s0167-0115(99)00039-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  5 in total

1.  No pain, no gain: the useful function of angina.

Authors:  Roberto Bolli; Ahmed Abdel-Latif
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

2.  Intrinsic cardiac ganglia and acetylcholine are important in the mechanism of ischaemic preconditioning.

Authors:  J M J Pickard; N Burke; S M Davidson; D M Yellon
Journal:  Basic Res Cardiol       Date:  2017-01-13       Impact factor: 17.165

3.  A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina.

Authors:  Christophe Depre; Lubomir Antalik; Amaal Starling; Michael Koren; Osaro Eisele; Robert A Lenz; Daniel D Mikol
Journal:  Headache       Date:  2018-05       Impact factor: 5.887

Review 4.  Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.

Authors:  Muntasir Billah; Anisyah Ridiandries; Usaid Allahwala; Harshini Mudaliar; Anthony Dona; Stephen Hunyor; Levon M Khachigian; Ravinay Bhindi
Journal:  Oncotarget       Date:  2019-01-04

5.  Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model.

Authors:  Amin Al-Awar; Nikoletta Almási; Renáta Szabó; Istvan Takacs; Zsolt Murlasits; Gergő Szűcs; Szilvia Török; Anikó Pósa; Csaba Varga; Krisztina Kupai
Journal:  Int J Mol Sci       Date:  2018-10-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.